Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Essen Biotech
Azienda Ospedaliero-Universitaria di Parma
University of Nebraska
Ohio State University Comprehensive Cancer Center
Mayo Clinic
University Health Network, Toronto
Cancer Research UK
Arcus Biosciences, Inc.
University of Alberta
Taproot Health
Cedars-Sinai Medical Center
Sanguine Biosciences
Cancer Support Community, Research and Training Institute, Philadelphia
University of Pennsylvania
Scripps Health
Celgene
Memorial Sloan Kettering Cancer Center
Shenzhen BinDeBio Ltd.
CureOne
Celgene
Wake Forest University Health Sciences
Novartis
Mirna Therapeutics, Inc.
Shenzhen Second People's Hospital
Celldex Therapeutics
M.D. Anderson Cancer Center
Bayer
Rutgers, The State University of New Jersey
The Cleveland Clinic
INSYS Therapeutics Inc
SCRI Development Innovations, LLC
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center